Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab and IVIG for Desensitization in Kidney Transplant
NCT00642655Phase 2Completed
- Sponsor
- Cedars-Sinai Medical Center
- Start
- Sep 2005
- Primary completion
- May 2007
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab, intravenous immunoglobulin G in kidney transplantation, sponsored by Cedars-Sinai Medical Center. Started Sep 2005; status: completed.
02
Drugs
rituximabintravenous immunoglobulin G
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT00642655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00642655.